On this page you can find out about studies we are currently delivering and upcoming studies that will be opening at our centre soon.

Open Studies (4)

    E.mbrace

    Study date: 26 May 2022

    Status: Open

    People who have a history of urinary tract infection (UTI) may be at risk of developing a bloodstream infection caused by a bacteria called E. coli. The E.mbrace study is now enrolling adults 60 years of age or older who have had a UTI in the past two years.

    To find out more about the E.mbrace study contact us on: PRCLeicester@uhl-tr.nhs.uk

    COVID-19 Vaccine Study: Moderna

    Study date: 28 March 2022

    Status: Open

    We are running a clinical trial investigating whether a new booster vaccine can provide better protection against the COVID-19 Omicron variant when compared to a booster dose of Moderna’s COVID-19 vaccine, Spikevax. This trial is sponsored by Moderna.

    ARISE-HF

    Study date: 12 August 2021

    Status: Open

    People with diabetes can develop issues with the structure and function of their heart muscle known as diabetic cardiomyopathy. The ARISE-HF study is investigating if a new medicine, called AT-001, can prevent this condition from progressing to a more serious stage of heart failure. The study is recruiting people with type 2 diabetes who will either receive the new medicine or a dummy (placebo) treatment.

    DETA

    Study date: 20 May 2021

    Status: Open

    Dapagliflozin is a commonly used medicine in diabetes care, it helps control blood sugar and promotes weight-loss. The DETA trial is investigating if this medicine also improves physical health, the ability to undertake daily activities, and whether its effects can be further improved when paired with an exercise programme.

Upcoming Studies (0)

There are currently no upcoming studies.

View all PRC: Leicester studies, including closed studies.

Related pages